To investigate the effects of anti-Scg3 hAb on severe OIR in vivo, we performed fluorescein angiography (FA) to quantify arterial tortuosity and venous dilation, which are two key manifestations of severe ROP. The gene discussed is SCG3; the disease is retinopathy of prematurity.